Non-Antibody Products — page 133 of 187
Non-Antibody Products
Page 133 of 187
| Name | Description | Size | Catalog # | Supplier | |
|---|---|---|---|---|---|
| FOY-251 | An active metabolite of camostat; inhibits TMPRSS2 (IC50 = 33.3 n… | 10 mg | 36051-10 |
 CAYMAN CHEMICAL COMPANY |
More Info |
| FOY-251 | An active metabolite of camostat; inhibits TMPRSS2 (IC50 = 33.3 n… | 5 mg | 36051-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| FOY-251 | An active metabolite of camostat; inhibits TMPRSS2 (IC50 = 33.3 n… | 500 µg | 36051-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
| P9R | Defensin like peptide with potent antiviral activity. Purity > 95% by HPLC… | 1 mg | orb1140591 |
 BIORBYT LTD. |
More Info |
| MutaPLEX® RespiraScreen 1, RT-PCR | SARS-CoV-2, extracted from biological specimens. | 96 tests | KG192796 |
 IMMUNDIAGNOSTIK AG |
More Info |
| Boceprevir-d9 | An internal standard for the quantification of boceprevir by GC- or LC-MS,, | 500 µg | 31461-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Camostat-d6 (hydrochloride) | An internal standard for the quantification of camostat by GC- or LC-MS | 1 mg | 30984-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Camostat-d6 (hydrochloride) | An internal standard for the quantification of camostat by GC- or LC-MS | 500 µg | 30984-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lipid 14 | with the SARS-CoV-2 spike glycoprotein. | 10 mg | 38589-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lipid 14 | with the SARS-CoV-2 spike glycoprotein. | 25 mg | 38589-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lipid 14 | with the SARS-CoV-2 spike glycoprotein. | 5 mg | 38589-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lipid 14 | with the SARS-CoV-2 spike glycoprotein. | 50 mg | 38589-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV-2 Spike S1 (Q52R, A67V, 69-70 deletion, 144 deletion, E484K, D614G, Q677H) HEK293 Cell | HEK293 Cell SARS-CoV-2 Spike S1 (Q52R, A67V, 69… | 300µg | 40591-V08H29L |
 SINO BIOLOGICAL, INC. |
More Info |
| FDA-Approved Drugs Screening Library | For screening FDA-approved drugs; contains ~892 compounds as 10 mM stock s… | 25 µL | 23538-25µL |
CAYMAN CHEMICAL COMPANY |
More Info |
| FDA-Approved Drugs Screening Library | For screening FDA-approved drugs; contains ~892 compounds as 10 mM stock s… | 50 µL | 23538-50µL |
CAYMAN CHEMICAL COMPANY |
More Info |
| 25-hydroxy Cholesterol | M); inhibits replication of SARS-CoV-2 in Vero cells (EC… | 10 mg | 11097-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 25-hydroxy Cholesterol | M); inhibits replication of SARS-CoV-2 in Vero cells (EC… | 100 mg | 11097-100 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 25-hydroxy Cholesterol | M); inhibits replication of SARS-CoV-2 in Vero cells (EC… | 25 mg | 11097-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 25-hydroxy Cholesterol | M); inhibits replication of SARS-CoV-2 in Vero cells (EC… | 5 mg | 11097-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV-2 Spike S1 (E154K, L452R, E484Q, D614G, P681R) HEK293 Cell Lysate | HEK293 Cell SARS-CoV-2 Spike S1 (E154K, L452R, E484Q, D6… | 300µg | 40591-V08H19L |
SINO BIOLOGICAL, INC. |
More Info |
| SARS-CoV-2 Spike S1 NTD (T19R, T95I, G142D, 156-157 deletion, R158G) Protein (His Tag) | A DNA sequence encoding the SARS-CoV-2 Spike S1 NTD (YP_… | 100µg | 40591-V08H36 |
SINO BIOLOGICAL, INC. |
More Info |
| Covidyte™ IF670 | A fluorogenic substrate for coronavirus Mpro; ex / em = 656 / 670 nm | 100 test | 33768-100 |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD (R683A, R685A, F817P, A892P, A899P, A942P, K986P, V987P | HEK293 Cell SARS-CoV-2 (2019-nCoV) Spike S1+S| 300µg |
40589-V08H4L |
|
SINO BIOLOGICAL, INC.
More Info
|
|
| Saquinavir-d9 | An internal standard for the quantification of saquinavir by GC- or LC-MS | 1 mg | 28906-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Umifenovir-d6 (hydrochloride) | An internal standard for the quantification of arbidol by GC- or LC-MS | 1 mg | 31494-1 |
CAYMAN CHEMICAL COMPANY |
More Info |